Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Cartesian Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 102 | 2 | 93 | −7 |
| Shares | 57.8M | 30.6K | 60.6M | +2.75M (+4.8%) |
| Value | $71.6M | $37.0K | $79.3M | +$7.81M (+10.9%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mangrove Partners | 7,260,419 | $9.51M | 0.73% |
| EcoR1 Capital, LLC | 3,500,000 | $4.58M | 0.16% |
| K2 Principal Fund, L.P. | 1,013,927 | $1.33M | 0.23% |
| Rubric Capital Management LP | 721,245 | $945.0K | 0.05% |
| Ergoteles LLC | 366,000 | $479.0K | 0.01% |
| Fred Alger Management, LLC | 221,222 | $290.0K | 0.00% |
| Qube Research & Technologies Ltd | 109,447 | $143.0K | 0.00% |
| Bailard, Inc. | 50,000 | $66.0K | 0.00% |
| Man Group plc | – | $61.0K | 0.00% |
| Private Advisor Group, LLC | 35,200 | $46.0K | 0.00% |
| LMR Partners LLP | 32,834 | $43.0K | 0.00% |
| Squarepoint Ops LLC | 27,760 | $36.0K | 0.00% |
| Boothbay Fund Management, LLC | 26,785 | $35.0K | 0.00% |
| Balyasny Asset Management LLC | 23,642 | $31.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 13,534 | $18.0K | 0.00% |
| Pinz Capital Management, LP | 10,600 | $14.0K | 0.01% |
| Captrust Financial Advisors | 1,500 | $2.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 56 | $0 | 0.00% |
| Ellevest, Inc. | 68 | $0 | 0.00% |
| Moisand Fitzgerald Tamayo, LLC | 100 | $0 | 0.00% |
Sold out (27)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 19,032 | $23.0K |
| Amalgamated Financial Corp. | 11,562 | $14.0K |